Publication:
Opposite malaria and pregnancy effect on oral bioavailability of artesunate - A population pharmacokinetic evaluation

dc.contributor.authorFrank Kloproggeen_US
dc.contributor.authorRose McGreadyen_US
dc.contributor.authorAung Pyae Phyoen_US
dc.contributor.authorMarcus J. Rijkenen_US
dc.contributor.authorWarunee Hanpithakponen_US
dc.contributor.authorHla Hla Thanen_US
dc.contributor.authorNathar Hlaingen_US
dc.contributor.authorNaw Thida Zinen_US
dc.contributor.authorNicholas P.J. Dayen_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.authorFrançois Nostenen_US
dc.contributor.authorJoel Tarningen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-11-23T10:34:33Z
dc.date.available2018-11-23T10:34:33Z
dc.date.issued2015-10-01en_US
dc.description.abstract© 2015 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of The British Pharmacological Society. Aim The aim was to compare the pharmacokinetic properties of artesunate and dihydroartemisinin in the same women: i) pregnant with acute uncomplicated malaria on day 1 and 2, ii) pregnant with convalescent malaria on day 7 and iii) in a healthy state 3 months post-partum on day 1, 2 and 7. Methods Non-linear mixed-effects modelling was used to compare plasma concentration-time profiles of artesunate and dihydroartemisinin over 7 days of treatment following oral and intravenous artesunate administration to pregnant women with uncomplicated Plasmodium falciparum malaria during their second or third trimesters of pregnancy. The same women were restudied 3 months after delivery when fully recovered. Non-compartmental results of the same study have been published previously. Results Twenty pregnant patients on the Thailand-Myanmar border were studied and 15 volunteered to be restudied 3 months post-partum. Malaria and pregnancy had no effect on the pharmacokinetic properties of artesunate or dihydroartemisinin after intravenous artesunate administration. However, malaria and pregnancy had opposite effects on the absorption of orally administered artesunate. Malaria increased the absolute oral bioavailability of artesunate by 87%, presumably by inhibiting first pass effect, whereas pregnancy decreased oral bioavailability by 23%. Conclusions The population pharmacokinetic analysis demonstrated opposite effects of malaria and pregnancy on the bioavailability of orally administered artesunate. Lower drug exposures during the second and third trimesters of pregnancy may contribute to lower cure rates and thus the development of drug resistance. Dose optimization studies are required for artesunate containing artemisinin-based combination therapies (ACTs) in later pregnancy.en_US
dc.identifier.citationBritish Journal of Clinical Pharmacology. Vol.80, No.4 (2015), 642-653en_US
dc.identifier.doi10.1111/bcp.12660en_US
dc.identifier.issn13652125en_US
dc.identifier.issn03065251en_US
dc.identifier.other2-s2.0-84942549519en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/36307
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84942549519&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleOpposite malaria and pregnancy effect on oral bioavailability of artesunate - A population pharmacokinetic evaluationen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84942549519&origin=inwarden_US

Files

Collections